Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
16.20
+0.03 (0.19%)
At close: Nov 7, 2025, 4:00 PM EST
15.53
-0.67 (-4.15%)
After-hours: Nov 7, 2025, 5:10 PM EST
Keros Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$20.67
Upside
+27.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -1.23% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +23.46% | Aug 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $32 → $18 | Strong Buy → Hold | Downgrades | $32 → $18 | +11.11% | Jun 10, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | -7.41% | May 30, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $41 → $26 | Buy | Maintains | $41 → $26 | +60.49% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $25 | Strong Buy | Maintains | $40 → $25 | +54.32% | May 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $43 → $25 | Strong Buy | Maintains | $43 → $25 | +54.32% | Apr 9, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | -7.41% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +146.91% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +60.49% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $40 | Strong Buy | Maintains | $47 → $40 | +146.91% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $15 | Buy | Maintains | $40 → $15 | -7.41% | Jan 17, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $47 → $15 | Buy → Hold | Downgrades | $47 → $15 | -7.41% | Jan 17, 2025 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $41 | Buy | Maintains | $44 → $41 | +153.09% | Jan 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.